Scientists Successfully Slow Down Light by 10,000 Times!

An illustration depicts gravitational waves stretching and squeezing space-time in the universe, June, 2023. (AP Photo)
An illustration depicts gravitational waves stretching and squeezing space-time in the universe, June, 2023. (AP Photo)
TT

Scientists Successfully Slow Down Light by 10,000 Times!

An illustration depicts gravitational waves stretching and squeezing space-time in the universe, June, 2023. (AP Photo)
An illustration depicts gravitational waves stretching and squeezing space-time in the universe, June, 2023. (AP Photo)

A new study demonstrates a method for slowing down light that promises to be one of the most useful approaches yet.

The researchers behind the breakthrough, from Guangxi University and the Chinese Academy of Sciences in China, say that their method could benefit computing and optical communication.

Light zipping through the emptiness of space moves at one speed and one speed only - 299,792 kilometers (about 186,000 miles) per second. Yet if you throw a mess of electromagnetic fields into its path, such as those surrounding ordinary matter, that extraordinary velocity starts to slow.

Most transparent materials will slow light by a tiny fraction. It's the changes in speed that cause light to bend as it passes from one medium to another.

But really putting the brakes on requires special materials like photonic crystals or even super-chilled quantum gases.

"We envision that our work provides an entirely new direction for realizing ultra-strong light-matter interactions in nanophotonic chips," write the researchers in their published paper.

The new method builds on what's known as electromagnetically induced transparency (EIT), which uses a clever bit of laser trickery to manipulate electrons inside gas that's stored in a vacuum – essentially turning it from opaque to transparent, reported the Science Alert website. This means laser light can pass through, but because of how it has been manipulated, it also slows down. That makes it very interesting for physicists, but the approach also means a lot of the light and energy is lost along the way.

To reduce this loss and improve the whole system's efficiency, the researchers took some of the principles of EIT in controlling light and designed a new material to slow down light.

The material is a kind of metasurface (a synthetic, 2D structure with properties unlike any in nature).

The metasurfaces designed by the team were made from very thin layers of silicon – like today's computing chips – and were shown to be much better than existing options.

Based on the results obtained by the researchers, light can be slowed down by more than 10,000 times in this system.

At the same time, the light loss is reduced by more than five times compared with other comparable methods. Key to the new approach is the way that the tiniest building blocks of the metasurface (known as meta-atoms) are positioned. In this case, they're essentially close enough to merge together, which in turn affects the way that light is handled as it passes through.

The end result is all of this complex science is better control over how light travels.

As light plays such a key role in everything from broadband internet to quantum computing, there's a multitude of potential applications.

It's not the only way that scientists have found to further slowdown light, beyond the natural slowing that happens in substances like water, but its effectiveness and its scalability make it a promising option for further study.

"With these findings, our study opens a new route for tailoring light flow in metasurfaces," write the researchers.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”